Skip to content

ReOxy Therapy in the Rehabilitation of Chronic Low Back Pain Patients With Comorbidity

CompletedNot applicableNCT05053672
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The aim of this study is to assess the effect of the respiratory therapy method based on short-term intermittent exposures to hypoxia and hyperoxia (ReOxy therapy) on the pain intensity, restoration of the lumbar range of motion, physical capacity, disability, mental and vegetative status in Chronic Low Back Pain patients with Multiple Chronic Conditions.

Study details

Official title
The Respiratory Therapy Method Based on Short-term Intermittent Exposures Hypoxia and Hyperoxia (ReOxy Therapy) in the Rehabilitation of Chronic Low Back Pain Patients With Cardiac or Pulmonary Comorbidities: a Randomized Controlled Trial
Conditions
Interventions
  • Device: ReOxy
  • Device: Sham ReOxy
Sponsor
Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine
Start date
2021-06-01
Primary completion
2022-04-15
Sex
All
Age range
from 18 Years to 75 Years
Results posted
No results posted in this snapshot
Countries
Russia
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patient with non-specific chronic low back pain for at least 3 months; * A pain intensity of at least 5 points measured by 0 -10 points pain rating scale; * Co-morbidity - IHD and/or CHF and/or COPD and/or chronic bronchitis) * Willing and able to consent, complete all assessment and study procedures; Exclusion Criteria: * Specific types of back pain (metastatic cancer or bone cancer or secondary cancers, vertebral fractures, spinal infection, active inflammatory disease); * Low back surgery within past 3 months; * Serious cardiovascular, cerebrovascular, neuromuscular and other systemic diseases or other diseases affecting physical activity; * Any significant systemic illness or medical condition that could affect safety or compliance with study; * Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year; * Tumour disease except being successfully treated and off treatment with \>2 years. Tumour disease except being successfully treated and off treatment with \>2 years. * Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05053672